INSIGHTS ON DRUG DEVELOPMENT
-
Streamlining Drug Development: From Developability Assessment To High-Concentration Formulation Development
Explore a strategic approach to accelerating biologics formulation by gaining early insight into molecular properties and optimizing high-concentration conditions with minimal protein input.
-
Payload-Linker CMC Services High-Potency R&D And GMP Manufacturing
A closer look at how advanced containment, continuous processing, and integrated CMC workflows help address payload–linker challenges, improve safety, and enable scale-up of antibody–drug conjugates.
-
A Fast And Simple ddPCR Assay For In-Depth AAV Characterization
Achieve precise AAV characterization with a streamlined digital assay. This video illustrates a rapid, four-step workflow that delivers accurate empty-to-full ratios in under eight hours.
-
Silyl Ether Linkers For Hydroxyl-Bearing Payload Conjugates
Discover an innovative approach to drug conjugation that expands the range of molecules suitable for targeted therapies while preserving their biological activity and enabling controlled drug release.
-
Alzheimer's Disease Pathway3/24/2025
Alzheimer’s disease (AD) affects 50 million people globally, causing cognitive decline. Explore the signaling pathways of amyloid beta and tau proteins, linking them to neuronal death and AD symptoms.
-
An All-In-One Solution For Residual DNA Quantitation5/22/2025
Explore an all-in-one solution for residual DNA quantitation with a 3D lab tour with virtual demos, videos, and interactive instrument guides to experience the full workflow.
-
White Paper: Characterization Of Spray Dried Biologics5/7/2025
Discover how spray drying can transform the formulation of complex biologics by improving stability, delivery, and functionality, with insights into the critical techniques and strategies needed for successful development.
-
Fast And Accurate Detection Of Alzheimer's Disease Targets9/17/2024
In this study, the detection of three Alzheimer’s disease targets are highlighted: Human BDNF (Brain-derived neurotrophic factor), Tau, and TREM2 (Triggering receptor expressed on myeloid cells 2).
-
Advancing GLP-1 Analog Drug Development Using A Variety Of Techniques6/27/2025
Discover how SEC-MALS reveals the aggregation behavior of GLP-1 analogs like semaglutide and liraglutide, which are critical for ensuring the stability, efficacy, and safety of peptide therapeutics.
DRUG DEVELOPMENT SOLUTIONS
-
Gain insight into how faster structural elucidation is possible with integrated mass spectrometry workflows that combine intelligent data analysis, spectral matching, and automation.
-
Boost genomics productivity with a solution built for speed, precision, and high throughput with extended walkaway times and reliable performance that helps teams get more done.
-
A new collaboration helps to remove obstacles from the critical path, reduce development risks, eliminate the white space in pre-clinical drug development, and shorten the pathway to clinical development.
-
Get Systematic Chemical Names for Structures, and Produce Structures from Names
ACD/Name generates chemical names according to IUPAC rules, converts chemical names to structures, and easily handles challenging areas of nomenclature.
- Generate names for organic; biochemical; and some inorganic, organometallic, and polymer structures
- Convert systematic or trivial names to structures
-
Digital microscopy with automated brightfield, fluorescence, and Digital Confocal imaging
The ImageXpress® Pico Automated Cell Imaging System is more than a digital microscope, combining high-resolution imaging with powerful analysis. Whether running fluorescence imaging or brightfield assays, the automated imager features a comprehensive portfolio of preconfigured protocols for cell-based assays to shorten the learning curve, so you can start running experiments quickly.